Ebv Clinical Trials 2023

Ebv Clinical Trials 2023

Ebv research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in ebv clinical trials today.

Ebv Clinical Trials

Here are the 6 most popular medical studies for ebv

Popular filter options for ebv trials

Diffuse Large B-Cell Lymphoma Clinical Trials

View 14 Diffuse Large B-Cell Lymphoma medical studies.

EBV Infection Clinical Trials

View 13 EBV Infection medical studies.

EBV Positive Clinical Trials

View 7 EBV positive medical studies.

Ebv Clinical Trials With No Placebo

View 38 ebv medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to ebv

What are the top hospitals conducting ebv research?

Cutting-edge clinical trials aimed at tackling the complexities of Epstein-Barr virus (EBV) are being conducted at some of the top hospitals across North America. In Houston, Texas Children's Hospital leads the charge with an impressive 11 ongoing EBV trials and a total of 15 studies throughout its history. This renowned institution embarked on its first EBV trial back in 1993, setting a precedent for groundbreaking research into this viral infection that affects millions worldwide. Nearby, Houston Methodist Hospital is also making significant strides with eight active EBV trials and a noteworthy track record of 11 previous investigations since their initial study in 1993.

Venturing north to Toronto, Canada's Princess Margaret Cancer Centre has recently joined the forefront by delving into three active EBV trials—an exciting advancement given their relatively short history in researching this virus. Their pioneering work began just last year in 2021, demonstrating their commitment to unraveling the mysteries surrounding EBV and developing innovative treatment options.

Further east in Washington, D.C., Children's National Medical Center stands as a powerhouse for pediatric medicine and is actively engaged in three ongoing EBV clinical trials. Since conducting their inaugural trial in 2013, they have remained dedicated to understanding and combating this challenging viral infection specifically among young patients.

Finally, Roswell Park Comprehensive Cancer Center located in Buffalo contributes significantly to advancing our knowledge about EBV through three currently active clinical trials alongside three historical studies dating back to 2018 when they initiated their first exploration into this field.

These esteemed institutions exemplify the importance placed on finding effective treatments for individuals affected by Epstein-Barr virus infections. By relentlessly pursuing medical breakthroughs through rigorous research efforts on multiple fronts, they offer hope not only to those directly impacted but also potential solutions that could transform future healthcare practices globally

Which are the best cities for ebv clinical trials?

When it comes to EBV clinical trials, several cities emerge as top contenders for cutting-edge research. Houston, Texas leads the pack with 28 active trials investigating iCaspase9-transduced T cells, MABEL CTLs, and EBV-specific T cells. New york, New York follows closely behind with 15 ongoing studies focusing on tabelecleucel, Posoleucel (ALVR105), and Cisplatin. Atlanta, Georgia boasts 13 active trials exploring treatments like Cisplatin, Posoleucel (ALVR105), and tabelecleucel. Meanwhile, Boston, Massachusetts contributes to the field with 12 ongoing trials examining treatments such as Cisplatin and Virus Specific T-cell (VST) infusion. Lastly, Los Angeles California hosts ten active trials studying Virus Specific T-cell (VST) infusion alongside other potential breakthroughs in EBV treatment methods. These cities offer individuals battling EBV access to a diverse range of clinical trial options that may pave the way for improved care outcomes in the future.

Which are the top treatments for ebv being explored in clinical trials?

Clinical trials are shedding light on the top treatments currently being explored for EBV. Among them, Posoleucel (ALVR105) stands out with one active trial and two all-time trials dedicated to combating this virus since its listing in 2021. Another promising contender is Rapidly generated virus specific T (R-MVST) cells, which made its debut in 2022 and has already garnered attention with one active trial and one all-time EBV trial. Lastly, Epstein-Barr Virus Specific T-Lymphocytes have also shown promise with one ongoing trial and a strong start after being listed in 2020. These innovative treatment options offer hope for those affected by EBV as researchers continue their efforts to find effective solutions.

What are the most recent clinical trials for ebv?

Recent clinical trials have been making significant strides in the field of Epstein-Barr virus (EBV) research, offering hope for improved treatment options. Among these trials is an interventional study that combines both Phase 1 and Phase 2 investigations, demonstrating promising potential against EBV. Additionally, another trial focuses on the use of pembrolizumab to combat EBV, with encouraging results from its Phase 2 stage. Another notable study explores a specific treatment arm targeting EBV in its Phase 2 stage. These advancements mark important milestones in our ongoing fight against this challenging viral infection.

What ebv clinical trials were recently completed?

A noteworthy clinical trial focused on the treatment of EBV infection has reached a significant milestone. Sponsored by Viracta Therapeutics, Inc., the VRx-3996 trial was successfully completed in March 2018. This study represents an important step forward in our understanding and potential management of this challenging viral infection. While further research is necessary to build upon these findings, it highlights the dedication of scientists and researchers in their quest for innovative therapies against EBV.